| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.33B | +3.7% |
| Cost of Revenue | $16.90B | -17.2% |
| Gross Profit | $10.71B | — |
| R&D Expense | $12.79B | +66.7% |
| SG&A Expense | $14.75B | +14.6% |
| Operating Income | $9.14B | -28.4% |
| Interest Expense | $2.81B | +26.3% |
| Pre-tax Income | $3.72B | -40.5% |
| Income Tax | -$570.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.52B | -56.9% |
| Short-term Investments | $31.0M | +1450.0% |
| Accounts Receivable | $10.92B | -2.1% |
| Inventory | $4.18B | +2.0% |
| Current Assets | $25.58B | -22.5% |
| Total Assets | $135.16B | +0.3% |
| Current Liabilities | $38.75B | +2.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.81B | -17.7% |
| Capital Expenditures | $974.0M | +25.4% |
| Investing Cash Flow | -$20.82B | -936.3% |
| Financing Cash Flow | -$5.21B | +69.7% |
| Free Cash Flow | $17.83B | -19.2% |
| -141.4% |
| Net Income | $4.28B | -12.0% |
| EPS (Basic) | $2.40 | -12.1% |
| EPS (Diluted) | $2.39 | -12.1% |
| Long-term Debt |
| $66.84B |
| +12.8% |
| Stockholders' Equity | $3.33B | -67.9% |